Cour Pharmaceuticals Development
About:
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Website: http://courpharma.com
Top Investors: Bristol-Myers Squibb, Lumira Ventures, Alpha Wave Global, Alpha Wave Ventures, JDRF T1D Fund
Description:
Cour Pharmaceuticals Development Co Inc operates in the pharmaceutical sector. Cour Pharmaceuticals Development Co Inc was founded in 2012 and is based in Elmhurst, Illinois.
Total Funding Amount:
$136M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Skokie, Illinois, United States
Founded Date:
2015-01-01
Contact Email:
info(AT)courpharma.com
Founders:
Brian Bock, Jim Herrmann, John J. Puisis
Number of Employees:
11-50
Last Funding Date:
2024-01-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai